Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
1,193.60
1,040.71
663.07
900.07
898.31
815.15
681.94
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,193.60
1,040.71
663.07
900.07
898.31
815.15
681.94
Raw Material Cost
717.78
631.47
439.86
545.24
576.18
513.77
422.97
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
140.87
118.27
96.67
94.66
0.00
71.24
61.01
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
22.87
15.31
3.02
3.06
1.19
0.55
3.90
Selling and Distribution Expenses
118.79
115.35
85.28
84.50
74.62
76.11
65.45
Other Expenses
-12.48
-7.78
-7.11
-5.30
4.15
-3.44
-4.42
Total Expenditure (Excl Depreciation)
875.53
802.59
553.76
674.45
693.53
627.32
509.15
Operating Profit (PBDIT) excl Other Income
318.09999999999997
238.1
109.3
225.6
204.8
187.8
172.8
Other Income
15.59
21.99
17.20
18.43
15.45
11.32
12.94
Operating Profit (PBDIT)
454.10
349.55
193.36
301.05
266.70
238.95
227.55
Interest
22.87
15.31
3.02
3.06
1.19
0.55
3.90
Exceptional Items
-14.05
0.66
13.82
0.42
0.00
-0.32
0.00
Gross Profit (PBDT)
475.82
409.24
223.21
354.83
322.13
301.37
258.97
Depreciation
120.44
89.44
66.84
57.24
46.47
39.79
41.83
Profit Before Tax
296.74
245.45
137.32
241.17
219.04
198.29
181.82
Tax
42.78
27.91
16.20
36.18
29.46
27.14
25.19
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
253.52
218.65
117.44
205.44
190.40
171.34
156.64
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
253.52
218.65
117.44
205.44
190.40
171.34
156.64
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.44
-1.11
3.68
-0.44
-0.81
-0.19
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
253.96
217.54
121.12
204.99
189.59
171.15
156.64
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,211.43
2,014.28
1,840.81
1,768.73
1,603.79
1,447.95
1,305.78
Earnings per share (EPS)
1.12
0.96
0.52
0.91
0.84
0.76
0.69
Diluted Earnings per share
1.12
0.96
0.52
0.91
0.84
0.76
0.69
Operating Profit Margin (Excl OI)
26.65%
22.88%
16.49%
25.04%
22.8%
23.04%
25.34%
Gross Profit Margin
34.95%
32.18%
30.79%
33.15%
29.56%
29.21%
32.8%
PAT Margin
21.24%
21.01%
17.71%
22.82%
21.2%
21.02%
22.97%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2024 is 14.69% vs 56.94% in Dec 2023
Consolidate Net Profit
YoY Growth in year ended Dec 2024 is 16.78% vs 79.60% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2024 is 33.85% vs 85.93% in Dec 2023
Interest
YoY Growth in year ended Dec 2024 is 49.67% vs 410.00% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2024 has improved from Dec 2023
Compare Annual Results Of Shenzhen Weiguang Biological Products Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
1,193.60
0
1,193.60
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,193.60
0
1,193.60
Raw Material Cost
717.78
0
717.78
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
140.87
0
140.87
Power Cost
0
0
0.00
Manufacturing Expenses
22.87
0
22.87
Selling and Distribution Expenses
118.79
0
118.79
Other Expenses
-12.48
0.00
-12.48
Total Expenditure (Excl Depreciation)
875.53
0
875.53
Operating Profit (PBDIT) excl Other Income
318.06
0.00
318.06
Other Income
15.59
0
15.59
Operating Profit (PBDIT)
454.10
0
454.10
Interest
22.87
0
22.87
Exceptional Items
-14.05
0
-14.05
Gross Profit (PBDT)
475.82
0
475.82
Depreciation
120.44
0
120.44
Profit Before Tax
296.74
0
296.74
Tax
42.78
0
42.78
Provisions and contingencies
0
0
0.00
Profit After Tax
253.52
0
253.52
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
253.52
0
253.52
Share in Profit of Associates
0
0
0.00
Minority Interest
0.44
0
0.44
Other related items
0.00
0.00
0.00
Consolidated Net Profit
253.96
0
253.96
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,211.43
0
2,211.43
Earnings per share (EPS)
1.12
0
1.12
Diluted Earnings per share
1.12
0
1.12
Operating Profit Margin (Excl OI)
26.65%
0%
0.00
26.65%
Gross Profit Margin
34.95%
0%
0.00
34.95%
PAT Margin
21.24%
0%
0.00
21.24%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 119.36 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 14.69% vs 56.94% in Dec 2023
Annual - Consolidate Net Profit
Consolidate Net Profit 25.40 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 16.78% vs 79.60% in Dec 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 43.85 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 33.85% vs 85.93% in Dec 2023
Annual - Interest
Interest 2.29 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 49.67% vs 410.00% in Dec 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 26.65%
in Dec 2024Figures in %
YoY Growth in year ended Dec 2024 has improved from Dec 2023






